# Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions

Study · id `cardio:ct-nct01747356` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01747356](<https://clinicaltrials.gov/study/NCT01747356>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01747356

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1000 participants.

## Technical summary

Registry record NCT01747356. Allocation not applicable; no masking; primary purpose treatment. Start 2013-02 (registry gives no type); primary completion 2015-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1000 participants (enrolled count; ClinicalTrials.gov record NCT01747356, source copy `cardio:ctgov-nct01747356-2015-11-17`, retrieved 2026-10-26)
- Start date: 2013-02 (registry gives no type) (ClinicalTrials.gov record NCT01747356, source copy `cardio:ctgov-nct01747356-2015-11-17`, retrieved 2026-10-26)
- Primary completion: 2015-11 (actual) (ClinicalTrials.gov record NCT01747356, source copy `cardio:ctgov-nct01747356-2015-11-17`, retrieved 2026-10-26)
- Completion: 2015-11 (actual) (ClinicalTrials.gov record NCT01747356, source copy `cardio:ctgov-nct01747356-2015-11-17`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01747356, source copy `cardio:ctgov-nct01747356-2015-11-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01747356-2015-11-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions
- Acronym: RESOLUTE-DM
- Condition: Coronary Artery Disease
- Condition: Diabetes
- Intervention (Device): Resolute stent treatment
- Lead sponsor: Shanghai Jiao Tong University School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Shanghai Jiao Tong University School of Medicine (`cardio:org-shanghai-jiao-tong-university-school-of-medicine`)

## Provenance

Content hash: 6ec1a84f5a70245ed23382aa12580d15ac550378e34e7f47f2a9cbd7a5c16e6c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
